Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating oral AK0901 for efficacy, safety, and tolerability in children with ADHD is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• AK0901

Snippet

Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: ADHD | Phase 3 | Status: UNKNOWN